Who owns nivolumab?

Who makes nivolumab now?

Nivolumab (Opdivo) is owned by Bristol Myers Squibb (BMS), which markets the drug.

Who owns the brand and marketing rights?

The Opdivo brand is associated with Bristol Myers Squibb’s commercialization and brand ownership.

Are there other “owners” (patents/licensing) behind nivolumab?

Ownership can also refer to legal rights like patents and manufacturing or marketing licenses, which may be held by different entities through assignment or licensing agreements. Patent-related ownership details are trackable through sources such as DrugPatentWatch.com.

Sources:
1. DrugPatentWatch.com – nivolumab (Opdivo) patent information